These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2502424)

  • 1. Plasma glycosyltransferase activity after ABO-incompatible bone marrow transplantation and development of an inhibitor for glycosyltransferase activity.
    Matsue K; Yasue S; Matsuda T; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Koizumi S
    Exp Hematol; 1989 Aug; 17(7):827-31. PubMed ID: 2502424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new concept of accommodation in ABO-incompatible kidney transplantation.
    Takahashi K
    Clin Transplant; 2005; 19 Suppl 14():76-85. PubMed ID: 15955174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
    Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
    Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M; Imoto S; Nakagawa T; Kai S; Hara H
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
    Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
    Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of an inhibitor of glycosyltransferase activity in a patient following an ABO incompatible liver transplant.
    Barbolla L; Mojena M; Cienfuegos JA; Escartín P
    Br J Haematol; 1988 May; 69(1):93-6. PubMed ID: 3132966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delay in red blood cell recovery after major ABO incompatible bone marrow transplantation].
    Fukuda M; Matsumoto K; Kojima S; Matsuyama T; Maeda H; Akatsuka Y; Tsuzuki S; Sughara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1991 Jan; 32(1):24-8. PubMed ID: 2020113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
    Lumkul R; Nathalang O; Arnutti P; Janyatham A; Torcharus K; Krutvecheo T; Sriphaisal T
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
    Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
    Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.